This company has access to no-doubt interesting technology - all power to 'em.
However, people should understand that a fundamental difference between ECQ and MSB technologies is MSB's is based on "off-the-shelf" [allogeneic] technology (pharmaceutical model and low cost of goods) while I understand ECQ's technology is "personalised medicine" [autologous](greater complexity and higher costs).
I hope ECQ has every success and will continue to watch, but people should be aware of the fundamental differences between this company and ECQ is all.
IF I've got it wrong and ECQ's technology is also "off-the-shelf" my error and apologies.
- Forums
- ASX - By Stock
- life scientist - regenerative medicine
This company has access to no-doubt interesting technology - all...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECQ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NXD
NEXTED GROUP LIMITED
Nick Poll, Managing Director
Nick Poll
Managing Director
SPONSORED BY The Market Online